PROTEMBIS
Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the completion of a € 30 million Series B financing round to support the enrollment of the PROTEMBO Investigational Device Exemption (IDE) Pivotal Trial (NCT05873816). The funding round was structured in two separate capital increases which have both been completed. It was co-led by a European consortium of VC investors including Sweden-based Segulah Medical Acceleration, Italy-based XGEN Venture, and Germany-based TechVision Fund. Other investors include Coparion, several large family offices, angel investors and a multinational medical device strategic.
“We are delighted to announce the completion of the round and would like to thank our existing investors as well as the new investors for their trust and confidence,” said Karl von Mangoldt and Conrad Rasmus Co-CEOs of Protembis. “It reflects the fact that the field of cerebral embolic protection is buoyant, and that future growth will be driven by younger and lower risk patients who have zero tolerance for brain injury risk when selecting to undergo transcatheter aortic valve replacement.”
Additionally, Protembis is proud to announce the addition of Keith D. Dawkins, MD, to the Board of Directors. Dr Dawkins has more than 35 years’ experience in the cardiovascular environment. With over 20 years as a practicing interventional cardiologist in the UK he has held research roles as a Fulbright Scholar at Stanford University, served as President of the British Cardiovascular Intervention Society, and authored more than 750 academic publications and presentations. Dr Dawkins has been the Chief Medical Officer (CMO) of Shockwave (NASDAQ:SWAV) since 2019, and this was preceded by his role as Global CMO at Boston Scientific where he held senior positions since 2008. He also serves as a member of the boards of Ventric Health LLC and JenaValve Technology Inc., as well as Chairman of InnovHeart s.r.l. Dr Dawkins will contribute his significant expertise to the clinical strategies of Protembis and the pre-commercial programs as the IDE study reaches its conclusion.
“To have such a visionary leader as Dr Dawkins join our Board of Directors is an exciting indication of the opportunities that cerebral embolic protection holds for future transcatheter therapies. We look forward to close collaboration as the field develops and our superiority trial gains momentum,” said Azin Parhizgar, PhD, Chairwoman of the Board of Directors.
“As a long-term believer in the need to protect the brain from all new lesions during transcatheter aortic valve replacement, I am very pleased to join Protembis,” said Dr Dawkins. “The ProtEmbo System and the clinical trial design are both novel and I am confident that they will be highly disruptive to the field of cerebral embolic protection, removing or mitigating many of the current issues that concern the physician community.”
About ProtEmbo® and Protembis
The ProtEmbo® Cerebral Protection System is an intra-aortic filter device that protects the entire brain from embolic material liberated during transcatheter aortic valve replacement (TAVR). It is a low-profile non thrombogenic system that shields all cerebral vessels, delivered through the left radial artery for optimal placement and stability. This is an ideal access site enabling physicians to avoid interference with TAVR equipment typically delivered through the femoral artery.
Protembis is a privately held emerging medical device company that has developed the ProtEmbo® Cerebral Protection System. The company strives to provide a simple and reliable solution to protect patients from brain injury during left-sided heart procedures, improving patient quality of life and reducing overall healthcare costs associated with brain injury during such procedures. The ProtEmbo System is currently undergoing clinical investigations.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240325053798/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Celonis Research Unveils: 89% of Business Leaders say AI Without Process Intelligence Fails to Deliver Expected Results5.2.2025 10:00:00 CET | Press release
The vast majority of decision makers surveyed (89%) said AI needs to have the context of how their business runs to deliver the expected results.81% of respondents said their companies plan to use AI specifically to improve business processes in the next 12 months.The majority (58%) of leaders worry that process shortcomings may limit AI’s contribution to their business. Celonis, the global leader in Process Mining and Process Intelligence, today released survey findings that demonstrate widespread recognition that AI requires Process Intelligence to be effective and relevant for the business. With Celonis Process Intelligence, AI gains the context it needs to understand how a business runs and how to make it run better. The 2025 Process Optimization Report shows that the vast majority of enterprise leaders (89%) say it’s crucial that AI has the context of how their business runs if it is going to deliver meaningful results and increase operational efficiency. The majority (58%) worry
Infobip Recognized as a Worldwide CPaaS Leader by IDC MarketScape for the Third Time5.2.2025 10:00:00 CET | Press release
Global cloud communications platform Infobip has been named as a Leader in the IDC MarketScape: Worldwide Communications Platform as a Service (CPaaS) 2025 Vendor Assessment. This is the third time that Infobip has been named a Leader in this report. According to the report, “Infobip is a key player in the CPaaS market with a global footprint and strong capabilities underpinned by its broad portfolio for enterprises as well as a carrier-grade service offering.” Courtney Munroe, Research Vice President, Worldwide Telecommunications Research at IDC, said:“Infobip has an agile organization structure and appetite for innovation to meet evolving enterprise requirements that stimulates continued expansion of its capabilities and global presence. The firm’s strong breadth and depth of services has enabled it to grow rapidly while maintaining a strong financial position.” Silvio Kutić, CEO at Infobip, said: “Over the last year, Infobip has continued to invest in innovative new services. For in
FoodChain ID and &Wider Announce Partnership for Responsible and Transparent Supply Chains That Protect Workers and Brands5.2.2025 10:00:00 CET | Press release
FoodChain ID, a provider of certification services and technology for the agriculture and food industry, and &Wider, a due diligence data company measuring worker engagement for responsible sourcing, announce their partnership for risk-based monitoring and auditing of worker conditions and engagement. The new service meets the demand from global brands to monitor and mitigate potential worker issues within their supply chains, as well as the requirements for transparent actions and reporting under the European Union’s (EU) Corporate Sustainability Due Diligence Directive (CSDDD) and Corporate Sustainability Reporting Directive (CSRD). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250205893945/en/ FoodChain ID and &Wider have announced a partnership for risk-based monitoring and auditing of food industry worker conditions to protect workers and food brands. (Photo: Business Wire) The CSDDD created an obligation for due dilig
Alipay Records Surge of China Inbound and Outbound Travel Spending During the 2025 Chinese New Year5.2.2025 07:59:00 CET | Press release
The number of Alipay transactions made by outbound Chinese travelers across the 90 million-strong Alipay+ global merchants network increased by 30% y-o-y. The top destinations for Chinese travelers are Singapore, Japan, Malaysia, Hong Kong SAR, and South Korea, showing the highest growth rate in total Alipay spending.China inbound travel spending via Alipay surged by 150% y-o-y in the first five days of the Chinese New Year (CNY) holiday. The number of inbound travelers using their 13 home e-wallets supported by the Alipay+ solution nearly doubled y-o-y during the first four days of the holiday.Alipay’s flagship Fortune Cards Campaign drew 600 million participants this year, reaching a cumulative of one billion users in the past decade since its launch in 2016. During the 2025 Chinese New Year, Alipay recorded a significant increase in China’s outbound and inbound travel spending. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home
Hitachi Establishes Its Fourth Corporate Venture Capital Fund to Capture Technology Turning Points and Future Growth Opportunities5.2.2025 07:00:00 CET | Press release
Total Assets Under Management (AUM) Reaches 1 Billion USD, Contributing to Sustainable Growth with a World-Class Investment Scale Hitachi, Ltd. (TSE: 6501, "Hitachi") today announced the establishment of the fourth fund of the corporate venture capital (hereinafter referred to as "CVC") fund"HV Fund" with a purpose to identify startups with the potential to create or disrupt large attractive markets, anticipate the next technological and social turning points, and generate future growth opportunities. The fourth fund will have a size of 400 million USD, which is the largest CVC fund managed by Hitachi to date. The fund will make strategic investments in startups with cutting-edge digital technologies such as data centers, distributed energy systems, future of work and industrial AI, as well as startups in new frontiers including bio, quantum, nuclear fusion, life science, space and adjacent technologies. With the establishment of the fourth fund, Hitachi's investment in CVC will reach
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom